IDIBELL and ICO participate in the discovery of a weakness that could be used to treat defective cancers for SMARCA4

by Hospital Universitari de Bellvitge

The study suggests that tumors with a genetically inactivated form of the chromatin remodeling protein SMARCA4 are highly sensitive to inhibitors of the KDM6 family of histone demethylases.

Read more

A new study about the reprogramming of lipid metabolism to combat cellular hepatocarcinoma

by Hospital Universitari de Bellvitge

A work coordinated by Isabel Fabregat – group leader of TGF-β and Cancer group at IDIBELL and CIBEREHD – University of Barcelona – studies the reprogramming of lipid metabolism and provides new...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Rethinking Alzheimer’s clinical trials...

by Fundació Clínic per a la Recerca Biomèdica

A paper published in Alzheimer’s & Dementia: The Journal of the Alzh...

Photos Stream